Listed

Perspective Therapeutics, Inc.

CATXNYSECIK 728387HealthcareFiscal year ends Dec 31

Reports and events: 405 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Perspective Therapeutics, Inc., Reports and events
FiledFormWhat it isAccession number
2025-05-1216:34 ET10-QQuarterly reportPeriod 2025-03-310000950170-25-069314
2025-05-1216:30 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0000950170-25-069301
2025-05-0117:05 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950170-25-061994
2025-04-2907:10 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950170-25-059557
2025-04-1616:30 ETDEF 14AProxy statementPeriod 2024-12-310000950170-25-054776
2025-04-1107:08 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950170-25-053023
2025-03-2816:05 ET10-K/AAnnual report, amendedPeriod 2024-12-310000950170-25-046758
2025-03-2616:14 ET10-KAnnual reportPeriod 2024-12-310000950170-25-045242
2025-03-2616:11 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0000950170-25-045227
2025-03-1707:05 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950170-25-039826
2025-03-0408:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950170-25-031324
2025-02-0316:09 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950170-25-012317
2025-01-2407:26 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950170-25-008603
2025-01-1308:36 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0000950170-25-004595
2025-01-0608:05 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-25-001712
2024-12-0421:31 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950170-24-133062
2024-11-2107:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950170-24-129487
2024-11-1507:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950170-24-127384
2024-11-1216:11 ET10-QQuarterly reportPeriod 2024-09-300000950170-24-125399
2024-11-1216:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-24-125353
2024-10-1108:31 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-24-236468
2024-09-2016:10 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits0000950170-24-108407
2024-09-0507:05 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950170-24-103731
2024-08-3016:10 ET8-K5.02 Departure or appointment of officers or directors0000950170-24-102338
2024-08-1917:20 ET8-K5.02 Departure or appointment of officers or directors0000950170-24-098685
2024-08-1317:11 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0000950170-24-096433
2024-08-1316:04 ET10-QQuarterly reportPeriod 2024-06-300000950170-24-096148
2024-08-1321:41 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950170-24-095707
2024-08-1217:22 ET8-K/A2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-24-095547
2024-08-1216:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-24-095411
2024-06-1416:05 ET8-K3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0000950170-24-073631
2024-05-3116:05 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0000950170-24-067300
2024-05-2916:05 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0000950170-24-065920
2024-05-2017:22 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950170-24-062549
2024-05-1516:05 ET10-QQuarterly reportPeriod 2024-03-310000950170-24-060427
2024-05-1507:02 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-24-060028
2024-04-1816:09 ETDEF 14AProxy statementPeriod 2024-04-180000950170-24-045554
2024-04-1616:05 ET8-K2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits0000950170-24-044769
2024-04-0816:05 ET8-K4.01 Change of auditor; 9.01 Financial statements and exhibits0000950170-24-042575
2024-04-0316:36 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001437749-24-010889
2024-03-2808:34 ET10-KAnnual reportPeriod 2023-12-310001437749-24-009696
2024-03-2807:42 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001437749-24-009691
2024-03-2517:16 ET8-K8.01 Other events0001437749-24-009256
2024-03-1916:36 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001437749-24-008542
2024-03-0811:22 ETSC 13D/AOwnership report, active investor, amended0001193125-24-063234
2024-03-0818:02 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001437749-24-007023
2024-03-0616:57 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001437749-24-006845
2024-02-0516:34 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001437749-24-003125
2024-02-0107:38 ETSC 13DOwnership report, active investor0001193125-24-021409
2024-01-2216:10 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001437749-24-001852

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 11:30 ET. Listed shows no prices and gives no investment advice.